MET-Targeting Anticancer Drugs—De Novo Design and Identification by Drug Repurposing
The Met protein is a cell surface receptor tyrosine kinase predominantly expressed in epithelial cells. Aberrant regulation of <i>MET</i> is manifested by numerous mechanisms including amplification, mutations, deletion, fusion of the <i>MET</i> proto-oncogene, and protein ov...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-07-01
|
| Series: | Drugs and Drug Candidates |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2813-2998/2/3/31 |